C4U CORPORATION
C4U Corporation is a developer of a genome editing technology intended to build various industrial applications.
C4U CORPORATION
Industry:
Biotechnology Environmental Consulting
Founded:
2018-03-15
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.crispr4u.jp
Total Employee:
1+
Status:
Active
Total Funding:
160 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apache Euro COVID-19 Pound Sterling Japanese Yen
Similar Organizations
Authentag
Authentag is a developer of a Big Data technology.
Boolv.com
Boolv.com is an One-stop solid waste recycling service platform
EdiGene
EdiGene is a biotechnology company that develops genome editing technologies.
Face Finding
Face Finding is a developer of face recognition technology.
GreenQ
GreenQ, a young innovative company, established in 2015 has a clear goal of bringing efficient technology.
LiRA Global
LiRA Global is a developer of lip-reading technology.
PrediXT
PrediXT is a developer of prediction technologies.
Qitan Technology
Qitan Technology is a Developer of a genome sequencing technology.
Current Employees Featured
Investors List
Osaka University Venture Capital
Osaka University Venture Capital investment in Seed Round - C4U Corporation
Osaka University Venture Capital
Osaka University Venture Capital investment in Seed Round - C4U Corporation
Official Site Inspections
http://www.crispr4u.jp
- Host name: s421-7.kagoya.net
- IP address: 133.18.14.8
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "C4U Corporation"
C4U CORPORATION Company Overview / History
C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology.CRISPR-Cas3 technology has strengths, such as โฆSee details»
C4U CORPORATION Leadership - crispr4u.jp
C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology. CRISPR-Cas3 technology has strengths, such as โฆSee details»
C4U Corporation - crispr4u.jp
December 10, 2024. C4U announces that our ongoing research and development of the gene and cell therapy utilizing CRISPR-Cas3 technology has been selected as a research project โฆSee details»
Info Sheet for Technical description - firm.or.jp
[email protected] / +81-80-4651-3645 [email protected] / +81-80-4384-9466 What kind of technology do you want to offer? * A. Clinical Development Pipelines โ Please see Sheet โฆSee details»
C4U Corporation - LinkedIn
Crispr4u.jp 31 Like Comment Share C4U Corporation 183 followers 2mo Report this post C4U will participate in Cell and Gene meeting on the Mesa in Arizona next week. ...See details»
Portfolio details - j-vgi.co.jp
Company name. C4U CORPORATION. Type of business. Medical(medical devices, drug discovery) Representatives. Akimitsu Hirai . Establishing a company. March 2018See details»
C4U Corporation - Crunchbase Company Profile & Funding
C4U Corporation life science start-up that specializes in the research and development of gene editing technologies.See details»
C4U Corporation | Global Startup Acceleration Program (GSAP) โฆ
C4U was founded in 2018 by Prof. Mashimo of the University of Tokyo. We are developing our proprietary gene editing technology, CRISPR-Cas3, which features unprecedented high target โฆSee details»
C4U Corporation - VentureRadar
Website: https://www.crispr4u.jp/ C4U Corporation is a biotechnology venture company founded in March 2018, by Dr. Tomoji Mashimo (currently Professor of University ...See details»
C4U CORPORATION Pipeline - crispr4u.jp
C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology. โฆSee details»
C4U CORPORATION - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for C4U CORPORATION of SUITA, OSAKA. Get the latest business insights from Dun & Bradstreet.See details»
C4Uๆ ชๅผไผ็คพ | InfoBase
ใCRISPR-Cas3ใใจใใใฒใใ ็ทจ้ๆ่กใๅบ็คๆ่กใจใใฆใ็ฃๆฅญ็ใงใฎๅฎ็จๅใ็ฎๆใในใฟใผใใขใใใงใใ้บไผๆง็พๆฃใฎใฟใชใใใ้บไผๅญใๆนๅคใใ็ดฐ่ใ็จใใๆฒป็็ญใซใใๆงใ ใช็พ โฆSee details»
C4U Corporation - Products, Competitors, Financials, Employees ...
Crispr4u.jp. Overview & Products; Financials; Founded Year 2018. Stage Series B | Alive. Total Raised $20.85M. Last Raised $10.91M | 2 yrs ago. Mosaic Score. The Mosaic Score is an โฆSee details»
C4U Company Profile 2024: Valuation, Funding & Investors
Www.crispr4u.jp. Formerly Known As. C for You, CRISPR. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Primary Industry. ... Japan External โฆSee details»
C4U CORPORATION Contact - crispr4u.jp
C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology. โฆSee details»
A New Hope for Epidermolysis Bullosa (โbutterfly childrenโ) โฆ
Oct 30, 2023 LUGANO, Switzerland & OSAKA, Japan--(BUSINESS WIRE)--#CRISPRCas3--Healiva SA (Healiva) and C4U Corporation (C4U) are pleased to announce that they have โฆSee details»
C4U - Overview, News & Similar companies | ZoomInfo.com
Oct 30, 2023 View C4U (www.crispr4u.jp) location in Osaka, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
C4U and Noile-Immune Biotech Partnership on PRIME Allogeneic โฆ
May 25, 2020 C4U and Noile-Immune Biotech Partnership on PRIME Allogeneic CAR-T Cell Therapy Using CRISPR/Cas3 Genome Editing Technology . Osaka and Tokyo, Japan, May โฆSee details»
C4U CORPORATION News - crispr4u.jp
Oct 8, 2024 C4U is a bio-venture company originated from Osaka University, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 โฆSee details»
ใKANSAI to the Worldใ#06 C4U -Kansai Startup Ecosystem
Aiming for Industrial Applications of Japan-based Genome Editing TechnologySee details»